Biotechnology Stock Doubled This: Fund Bets 1.2M Shares
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
We compare expense ratios across dividend growth ETFs to identify the lowest-cost options for long-term investing.
28,176 articlesA large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
BitMine expands its Ethereum hoard to 60,000 ETH worth about $126 million as it enters the Russell 1000 preliminary l...
Institutions are increasingly weighing Bitcoin as a potential reserve asset alongside gold, amid macro uncertainty an...
Starting with $500? This guide shows you how to pick the best fintech stocks with a small budget, build a balanced st...
A highly focused 3x Korea fund rides a memory-chip demand wave to striking gains, but risk factors and regulatory scr...
SoFi’s five-year arc has been a brutal test of conviction: a steep drawdown followed by a rebound as the fintech seek...
Big investors are quietly using a loophole to keep buying rental properties despite bans. This article breaks down wh...
As inflation sticks around, a bigger 2027 social security COLA could boost retirees’ monthly payments. Yet economists...
A modest income doesn’t lock you out of rental ownership. This guide shows a clear path to building a small portfolio...
A practical guide to using sketches to plan and manage wealth. Learn how Carl Richards' visual approach helps you tra...
Germany plans sweeping changes to its pension system in 2026. This article breaks down what the reforms could mean fo...
As markets swing in 2026, savers confront whether their 401(k) targets match reality. This report breaks down age-by-...